Aravive, Inc.
DelistedCIK 1513818fmd_1B3WE12AM2VEA8SDFER7YAGGZEManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2012 to Sep 30, 2023, 44 periods
Latest annual · FY2022
Millions- Total revenues
- 9
- Operating income
- (71)
- Net income
- (76)
- Free cash flow
- (65)
Latest quarter · Q3 FY2023
Millions- Total revenues
- 3
- Operating income
- (9)
- Net income
- 21
Key stats
Open AnalysisCompound annual growth
- Revenue, 3 yearsFY2019 to FY2022
- +24.3%
- Revenue, 5 yearsFY2017 to FY2022
- -25.6%
- Net income, 5 yearsFY2017 to FY2022
- n/m
Aravive, Inc. financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2022 | FY2021 | Change | Source |
|---|---|---|---|---|
| Revenue | $9.1 million | $7.4 million | +22.8% | 10-K 2023-03-15 · proof |
| Operating income | -$70.8 million | -$40.6 million | 10-K 2023-03-15 · proof | |
| Net income | -$76.3 million | -$39.2 million | 10-K 2023-03-15 · proof | |
| Cash from operating activities | -$65.1 million | -$32.2 million | 10-K 2023-03-15 · proof | |
| Free cash flow | -$65.1 million | -$32.2 million | 10-K 2023-03-15 · proof | |
| Total assets | $62.2 million | $67.8 million | -8.3% | 10-K 2023-03-15 · proof |
| Total liabilities | $51.5 million | $25.6 million | +101.4% | 10-K 2023-03-15 · proof |
| Cash and cash equivalents | $53.7 million | $59.4 million | -9.7% | 10-K 2023-03-15 · proof |
- What was Aravive, Inc.'s revenue in fiscal 2022?
- Aravive, Inc. reported revenue of $9.1 million for fiscal 2022 (the year ended Dec 31, 2022), against $7.4 million the year before (+22.8%). Source: the 10-K filed with the SEC on Mar 15, 2023. SEC
- What was Aravive, Inc.'s operating income in fiscal 2022?
- Aravive, Inc. reported operating income of -$70.8 million for fiscal 2022 (the year ended Dec 31, 2022), against -$40.6 million the year before. Source: the 10-K filed with the SEC on Mar 15, 2023. SEC
- What was Aravive, Inc.'s net income in fiscal 2022?
- Aravive, Inc. reported net income of -$76.3 million for fiscal 2022 (the year ended Dec 31, 2022), against -$39.2 million the year before. Source: the 10-K filed with the SEC on Mar 15, 2023. SEC
- What was Aravive, Inc.'s cash from operating activities in fiscal 2022?
- Aravive, Inc. reported cash from operating activities of -$65.1 million for fiscal 2022 (the year ended Dec 31, 2022), against -$32.2 million the year before. Source: the 10-K filed with the SEC on Mar 15, 2023. SEC
- What was Aravive, Inc.'s free cash flow in fiscal 2022?
- Aravive, Inc. reported free cash flow of -$65.1 million for fiscal 2022 (the year ended Dec 31, 2022), against -$32.2 million the year before. Source: the 10-K filed with the SEC on Mar 15, 2023. SEC
- What are Aravive, Inc.'s total assets?
- As of Dec 31, 2022, Aravive, Inc. reported total assets of $62.2 million, against $67.8 million a year earlier (-8.3%). Source: the 10-K filed with the SEC on Mar 15, 2023. SEC
- What are Aravive, Inc.'s total liabilities?
- As of Dec 31, 2022, Aravive, Inc. reported total liabilities of $51.5 million, against $25.6 million a year earlier (+101.4%). Source: the 10-K filed with the SEC on Mar 15, 2023. SEC
- What are Aravive, Inc.'s cash and cash equivalents?
- As of Dec 31, 2022, Aravive, Inc. reported cash and cash equivalents of $53.7 million, against $59.4 million a year earlier (-9.7%). Source: the 10-K filed with the SEC on Mar 15, 2023. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1513818&period_type=annual&limit=5"Information only, not investment advice.